Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
Eli Lilly' s blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the ...
Reuters on MSN23h
Analysis-Americans hungry for weight-loss drugs grapple with supply and insurance hurdles
Americans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk's weight-loss and diabetes drugs but cannot ...
Time on MSN23h
Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs
But the drug ... Eli Lilly and Novo Nordisk suggest fewer than 10% of GLP-1 study participants dropped out due to side ...
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...
Reuters7d
Eli Lilly gets nod to launch weight-loss drug in Hong Kong - Bloomberg News
Oct 27 (Reuters) - Eli Lilly (LLY.N), opens new tab expects to start selling its weight-loss drug in Hong Kong as ...
Eli Lilly Is Putting On Some Weight As Earnings Near
Eli Lilly and Company has shown rapid growth with significant revenue increases. Click here to find out why I've decided to ...
As Race To Best 'Miracle' Obesity Drug Heats Up, Ozempic Maker Novo Nordisk Tests New Hybrid Drug That Can Reduce Weight Up To 25%
Novo's development chief, Martin Holst Lange, has shown optimism about the drug's promise, though he refrained from making ...
US FDA warns against California facility making compounded weight-loss drugs
The U.S. Food and Drug Administration on Friday warned patients and health care professionals not to use compounded drugs, ...